PTAB Collects Amici on Tribal Immunity Dispute
Contributed by Ropes & Gray. Originally published on Patexia; republished here as part of the LexDana archive.
Tribal Immunity in Focus at PTAB
Previously I explained that the 7th amendment argument in Oil States and the 11th amendment argument for sovereign immunity from the PTAB are both tied to the same basic, threshold premise — IPR is a trial proceeding akin to an Article III lawsuit. Recent amicus filings supporting the petitioner echo that sentiment.
In response to the PTAB Order earlier this month authorizing amicus briefing, input from a number of organizations has been received. The complete set is linked below.
Amicus Curiae Brief of the Oglala Sioux Tribe (here)
Amicus Curiae Brief of the Public Knowledge and the Electronic Frontier Foundation (here)
Amicus Curiae Brief of Scholars (here)
Amicus Curiae Brief of Askeladden LLC (here)
Amicus Curiae Brief of Deva Holding A.S. (here)
Amicus Curiae Brief of the High Tech Inventors Alliance (here)
Amicus Curiae Brief of the Seneca Nation (here)
Amicus Curiae Brief of the NAIPEC (here)
Amicus Curiae Brief of U.S. Inventor, LLC (here)
Amicus Curiae Brief of the SIIA (here)
Amicus Curiae Brief of The National Congress of American Indians et al.(here)
Amicus Curiae Brief of Luis Ortiz and Kermit Lopez (here)
Amicus Curiae Brief of The Association for Accessible Medicines (here)
Amicus Curiae Brief of The BSA | The Software Alliance (here)
Amicus Curiae Brief of James R. Major (here)
Scott A. McKeown is an author of the Patents Post Grant.
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…